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In recent years, guidelines were published to
define indications, applications and delivery of
long-term mechanical ventilation (MV) [1, 2].
Non-invasive positive pressure ventilation
(NPPV) has been increasingly used in the manage-
ment of chronic respiratory insufficiency resulting
from neuromuscular and restrictive chest wall dis-
eases [3] and, also in chronic obstructive pul-
monary disease (COPD) [4] with controversial re-
sults.
Side-effects due to the interface may impact
the follow-up of these patients in 20-50% of cases
[5-7] and they account for an important problem
when dealing with discontinuation and lack of
compliance. Nonetheless, the selection of patients
[2], mode of ventilation [8], types of ventilator [9],
ventilator setting [10, 11] and apparatus needed for
MV [12-14] have claimed to account for these
conflicting results.
There is a lack of information regarding in-
hospital assessment and the plans to initiate and
prescribe NPPV. The present review proposes an
operative flow chart for optimisation of home
NPPV prescription which has been used since
2001 in two Italian rehabilitative centres.
As stressed in recent guidelines [2] the physician
needs to strictly test the correct indication for NPPV
in terms of correct diagnosis (neuromuscular disor-
ders or chest wall deformities rather than COPD)
and in terms of patient’s stability (see figure 1). Pa-
tient’s stability refers to general conditions, to respi-
ratory status in absence of any factor associated with
exacerbation, and to the psycho-social ability to cope
with a long-term MV [2] programme. In particular,
stability in COPD patients, has been defined as an
arterial pH > 7.35 and absence of acute exacerba-
tions in the four weeks preceding recruitment [4]. At
the same time, another key point is to accurately ex-
plain the in-hospital training and home NPPV pro-
grams to the patient and care-giver(s) in terms of;
a) expected results
b) outcome
c) necessity of program adherence and
d) strict long term follow up [2].
The second step of the ideal training process
(figure 1) requires the careful choice of: 1) venti-
lator, 2) mask, 3) apparatus (in terms of circuit and
expiratory valve) 4) mode of MV and 5) setting up
of MV.
Home NPPV is often prescribed after in-hospi-
tal practice sessions have been performed with the
commercial ventilators available at the moment
(often a single one), which may be not necessarily
the same one used by the patient at home. This
limits the possibility to select the best ventilator
“tailored” for the patient. Although the large ma-
jority of the so-called “home care” ventilators can
offer performances similar to those of the tradi-
tional and more expensive “ICU” ventilators [10,
15], it has been demonstrated that, at least in bench
studies, each ventilator may perform differently
[16-18]. One study has compared patients’ compli-
ance in the commonly prescribed commercial ven-
tilators [8]: however, no specific comparisons on
the physiological effects among these ventilators
have been reported yet.
In our laboratory we undertook a study [19] to
compare patient-ventilator interaction and patient
comfort with five different commercial bi-level
pressure home ventilators, all set on the basis of the
maximal tolerated Inspiratory Positive Airway
Pressure (IPAP). These ventilators were delivered
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Although in recent years guidelines have been pub-
lished in order to define indications, applications and de-
livery of long-term home non invasive mechanical ventila-
tion (HNMV), there is lack of information with regards to
in-hospital assessment, planning and training to initiate
and prescribe it.
Discontinuation and lack of compliance versus HNMV
may affect the follow-up of these patients adding a costly
burden for care.
The present review proposes an operative flow chart
for optimisation of HNMV prescription from initial pa-
tient’s selection to post discharge follow up including;
1. assessment of the correct choice of ventilator, inter-
faces, ventilation setting
2. Timing for different physiological monitoring (arteri-
al gases, mechanics, sleep)
3. Timing for clinical evaluation, machine adaptation,
carer training and long term follow-up.
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to 28 obstructed or restricted patients with chronic
ventilatory failure; we concluded that (despite a
great inter-subject variability in comfort) all these
ventilators are well tolerated, and produce similar
physiological effects thus fulfilling the aims of me-
chanical ventilation [2]. These findings suggest
that, in order to make informed decision when pre-
scribing a ventilator for NPPV to the individual pa-
tient, it is necessary to understand how the ventila-
tor tested actually performs in that patient, and how
it is accepted by the patient him/her self. For that
reason the choice of ventilator for home NPPV
should be made after comparing different ventila-
tors which are suitable to the individual patient.
Serious attention is also necessary to test dif-
ferent masks in order to minimize leaks and side
effects and also to obtain the best comfort. Never-
theless, poor literature is available in this specific
field: Navalesi and colleagues [12] demonstrated
that during application of NPPV the best comfort
is found with the use of nasal masks, whereas the
best improvements in minute ventilation and Pa-
CO2 are obtained using the facial mask.
The use of an appropriate exhalation device for
home ventilatory assistance to avoid significant
CO2 re-breathing is mandatory. Controversies re-
main if this goal may be obtained only with an ap-
propriate exhalation device (such as the “plateau”
expiratory valve) without compromising the deliv-
ered pressures and tidal volume [13] or also with
the traditional exhalation valve [14] Recent work
[2] shows that the majority of authors use pressure
assisted modalities rather than volume controlled
ones; in particular, the pressure support modality
has been demonstrated to be the most comfortable
method to chronically ventilate COPD patients
with respiratory failure [4, 8].
In clinical practice, home NPPV for COPD pa-
tients is prescribed as Nasal Pressure Support Ven-
tilation (NPSV), and it is set to achieve a decrease
in PaCO2 and an optimal patient’s compliance(“usual setting”). However, targeting the setting to
these objects gives no information on the respira-
tory muscle unloading and the intrinsic positive
end expiratory pressure (PEEPi) counterbalancing
(“physiological setting”). The application of ex-
trinsic positive end expiratory pressure (PEEPe) in
these patients has been shown to be the best to un-
load the diaphragm with an adequate titration [i.e.
80-90% of intrinsic dynamic positive end-expira-
tory pressure (PEEPi dyn)], whilst an incorrect set-
ting (for example in the case of over assistance)
may lead to further increase hyperinflation [20].
The “usual setting” and the “physiological setting”
might have different implications in clinical prac-
tice as demonstrated in a recent study performed
on stable COPD patients with chronic hypercapnia
[11]. This study supports the notion that NPSV set
either at patient’s comfort or tailored to the physi-
ological measurements provides similar improve-
ment in arterial blood gases (ABG) and unloading
of the respiratory muscles. However, the physio-
logical setting of inspiratory assistance and PEEPe
(with the need to use an invasive evaluation of
lung mechanics and respiratory muscles function)
may result in a reduction of inspiratory ineffective
efforts, which relate to the patient-ventilator dis-
synchrony [11]. Figure 1 shows in details the
modality of the settings more used in literature.
Figure 1 also indicates that clinical monitoring
of patient’s comfort, patient-ventilator interaction
and arterial saturation (SatO2) is necessary from
the beginning of MV [2]. In particular, ABG to test
the effect of the ventilation, the assessment of pa-
tient comfort and the appearance of any technical
problems (leaks, high pressure limit) are recom-
mended 60 minutes after MV application [2]. At
this stage patient’s co-operation, rather than imme-
diate clinical results, is the main aim.
Two different results are possible in the patient
under evaluation (see figure 1): arterial blood gases
(ABG) improvement or ABG unchanged/worsening:
1. If ABG is worsened and MV discomfort ap-
pears, then there is the possibility to change
apparatus (see above) and/or to add flow, vol-
ume and airway pressure by continuous moni-
toring (by means of a flow transducer); these
changes may therefore help physician to opti-
mise setting and to improve the patient’s com-
pliance [11]. Only in selected situations [11]
evaluation of lung mechanics (by means of oe-
sophageal balloon) may substantially lead to
improve the patient-ventilator interaction, to
avoid ineffective efforts, to physiologically re-
duce intrinsic PEEP (PEEPi dyn) and work of
breathing (WOB).
2. If an acceptable level of patient comfort with a
good response in terms of ABG is found, diur-
nal adaptation to MV can start. The recom-
mended protocol of application is targeted to
reach no less than four hours per day and no
less than two consecutive days of positive
adaptation [2]. Thereafter, nocturnal ventila-
tion may be tested: the assessment of nocturnal
compliance and SatO2 monitoring at the 3rd
consecutive night is usually performed. ABG
on spontaneous breathing with usual O2 supply
at waking up is assessed to evaluate the defin-
itive impact of MV during sleep. Question-
naires on sleep quality can also be adminis-
tered. Only in selected situations a full-night
polysomnography might be useful to assess
apnoeas, snoring or arousals and possibly, to
normalise them after proper setting.
Only when both diurnal and nocturnal adapta-
tions are acceptable, can in-hospital training for
the patient and the carer be proposed [2]. The
training consists of at least 6 lessons (by medical
doctors and nurses) lasting 30 to 45 minutes to il-
lustrate the use of mask, circuit, comfort flaps,
ventilator and cleaning procedures. Finally, it is al-
so essential to test the ability of the care-giver and
family members to collaborate with the home MV
programme.
Only at this step can a definitive prescription
of MV be assured to complete the discharge plan-
ning. A strict follow-up including clinical signs (i.
e. gastric inflation, coughing, etc.), mask and/or
ventilator discomfort and technical problems (i. e.
leaks) needs also to be planned.
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In conclusion, the prescription of home NPPV
is a hard task for doctors and it represents a kind of
challenge for a multidisciplinary team consisting
not only of the doctor himself, the nurse, the respi-
ratory therapist, the psychologist, but also of the
patient’s family and care-giver. Acceptance and
motivation to co-operate are essential and should
be proportional to the patient’s dependency.
The main goals of NPPV are to control symp-
toms linked to nocturnal hypo-ventilation, to im-
prove the patient’s quality of life and to reduce
morbidity and, (possibly) mortality in a cost-effec-
tive way. In-hospital assessment and planning are
necessary to initiate NPPV. A documented diagno-
sis and indications, an adequate setting and the pa-
tient’s compliance are essential for prescription.
The follow-up monitoring is also essential to con-
firm prescription each year; moreover, a re-evalu-
ation about the correct indication for NPPV and/or
alternative indication for tracheotomy and change
to invasive MV may be considered at this stage .
The process to properly assess and plan home
MV is the correct way to improve and stabilize
lung function, to increase the quality of life and to
prevent acute episodes of hypercapnia which are
often fatal recurrences in these kind of patients
with advanced respiratory disease.
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